Literature DB >> 7610931

Characterization of the mouse tartrate-resistant acid phosphatase (TRAP) gene promoter.

S V Reddy1, J E Hundley, J J Windle, O Alcantara, R Linn, R J Leach, D H Boldt, G D Roodman.   

Abstract

Tartrate-resistant acid phosphatase (TRAP) is an iron-binding protein that is highly expressed in osteoclasts. To characterize the regulation of TRAP gene expression, progressive 5' and 3' deletions of a 1.8 kb fragment containing the 5'-flanking sequence were fused to a luciferase reporter gene. Two nonoverlapping regions of this 1.8 kb fragment had promoter activity. The upstream promoter (P1) was located within the region from -881 bp to -463 bp relative to the ATG, while the downstream promoter (P2) was located between -363 bp to -1 bp in a region we have previously shown to be an intron in transcripts originating from the upstream promoter. A putative repressor region for the P2 promoter at -1846 bp to -1240 bp and a putative enhancer region at -962 bp to -881 bp relative to the ATG were identified. PCR analysis of promoter-specific transcription of the TRAP gene in various murine tissues showed that both promoters were active in several tissues. Transferrin-bound iron increased P1 promoter activity 2.5-fold and hemin decreased P1 promoter activity, but neither had any effect on P2 activity. These data show that the transcriptional regulation of the TRAP gene is complex and that iron may play a key role in TRAP gene regulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7610931     DOI: 10.1002/jbmr.5650100413

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  24 in total

1.  Aspirin inhibits osteoclastogenesis by suppressing the activation of NF-κB and MAPKs in RANKL-induced RAW264.7 cells.

Authors:  Yan-Ping Zeng; Chao Yang; Yuan Li; Yong Fan; Hong-Jun Yang; Bin Liu; Hong-Xun Sang
Journal:  Mol Med Rep       Date:  2016-06-30       Impact factor: 2.952

2.  Adenosine A1 receptor regulates osteoclast formation by altering TRAF6/TAK1 signaling.

Authors:  W He; B N Cronstein
Journal:  Purinergic Signal       Date:  2012-02-05       Impact factor: 3.765

3.  Inactivation of glycogen synthase kinase-3β is required for osteoclast differentiation.

Authors:  Hyun Duk Jang; Ji Hye Shin; Doo Ri Park; Jin Hee Hong; Kwiyeom Yoon; Ryeojin Ko; Chang-Yong Ko; Han-Sung Kim; Daewon Jeong; Nacksung Kim; Soo Young Lee
Journal:  J Biol Chem       Date:  2011-09-23       Impact factor: 5.157

4.  Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density.

Authors:  D Jia; C A O'Brien; S A Stewart; S C Manolagas; R S Weinstein
Journal:  Endocrinology       Date:  2006-08-24       Impact factor: 4.736

5.  Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone.

Authors:  Jumpei Teramachi; Hua Zhou; Mark A Subler; Yukiko Kitagawa; Deborah L Galson; David W Dempster; Jolene J Windle; Noriyoshi Kurihara; G David Roodman
Journal:  J Bone Miner Res       Date:  2014-06       Impact factor: 6.741

6.  PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts.

Authors:  Tomohiro Hikata; Hironari Takaishi; Jiro Takito; Akihiro Hakozaki; Mitsuru Furukawa; Shinichi Uchikawa; Tokuhiro Kimura; Yasunori Okada; Masahito Matsumoto; Akihiko Yoshimura; Riko Nishimura; Sakamuri V Reddy; Hiroshi Asahara; Yoshiaki Toyama
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

7.  Role of ATF7-TAF12 interactions in the vitamin D response hypersensitivity of osteoclast precursors in Paget's disease.

Authors:  Jumpei Teramachi; Yuko Hiruma; Seiichi Ishizuka; Hisako Ishizuka; Jacques P Brown; Laëtitia Michou; Huiling Cao; Deborah L Galson; Mark A Subler; Hua Zhou; David W Dempster; Jolene J Windle; G David Roodman; Noriyoshi Kurihara
Journal:  J Bone Miner Res       Date:  2013-06       Impact factor: 6.741

8.  Hexane-Soluble Fraction of the Common Fig, Ficus carica, Inhibits Osteoclast Differentiation in Murine Bone Marrow-Derived Macrophages and RAW 264.7 Cells.

Authors:  Young Ran Park; Jae Soon Eun; Hwa Jung Choi; Manoj Nepal; Dae Keun Kim; Seung-Yong Seo; Rihua Li; Woo Sung Moon; Nam-Pyo Cho; Sung-Dae Cho; Tae Sung Bae; Byung Il Kim; Yunjo Soh
Journal:  Korean J Physiol Pharmacol       Date:  2009-12-31       Impact factor: 2.016

9.  Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation.

Authors:  Fumiyo Ikeda; Riko Nishimura; Takuma Matsubara; Sakae Tanaka; Jun-ichiro Inoue; Sakamuri V Reddy; Kenji Hata; Kenji Yamashita; Toru Hiraga; Toshiyuki Watanabe; Toshio Kukita; Katsuji Yoshioka; Anjana Rao; Toshiyuki Yoneda
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

10.  Involvement of hydrogen peroxide in the differentiation of clonal HD-11EM cells into osteoclast-like cells.

Authors:  M J Steinbeck; J K Kim; M J Trudeau; P V Hauschka; M J Karnovsky
Journal:  J Cell Physiol       Date:  1998-09       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.